addressing under-representation of elderly patients in dlbcl clinical trials
Published 11 months ago • 74 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
1:23
defining elderly patients in the context of dlbcl treatment
-
3:47
underrepresentation of elderly patients with cll in clinical trials
-
4:46
current treatment options for older patients with dlbcl
-
3:09
novel strategies emerging for elderly patients with dlbcl and ongoing trials in this space
-
1:32
management and outcomes of elderly patients with lbcl
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
5:35
lymphoma - dr.rahul bhargava
-
1:09:24
update on immunotherapy in the treatment of lymphoma | lrf webinars
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:54
comparing various prognostic scores used to predict outcomes in elderly patients with dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:41
addressing diversity, equity, and inclusion in hematology clinical trials across europe
-
3:04
applying molecular understanding of dlbcl to management strategies
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
2:03
unmet needs in lbcl: treatment options for elderly or frail patients
-
3:57
the development of clinical guidelines for older patients with aml
-
0:53
ukall60 : identifying the standard of care for elderly patients with all
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
3:14
standard treatment of elderly patients with aml & evaluating idh inhibitors in younger patients
-
1:01
pitfalls in the diagnosis of lymphoid malignancies: interpreting pet scans
-
1:36
relative dose intensity in older dlbcl patients